Login / Signup

Did primary spontaneous pneumomediastinum risk factor alter in the period of COVID-19 pandemia?

Cemal AkerCelal Bugra SezenAyşegül İnci SezenMustafa Vedat DogruMerve ÖzbekMuzaffer MetinLevent CanseverMehmet Ali Bedirhan
Published in: Interactive cardiovascular and thoracic surgery (2021)
Having an age of more than 24 years was associated with a higher prevalence of pneumomediastinum in COVID-19 patients and emerged as an important risk factor. Multicentre studies with more cases are needed to determine whether pneumomediastinum is associated with additional other risk factors related to COVID-19.
Keyphrases
  • risk factors
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • clinical trial
  • study protocol
  • cross sectional
  • randomized controlled trial
  • case control
  • double blind